Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S Hakomori is active.

Publication


Featured researches published by S Hakomori.


FEBS Letters | 1997

Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate

Shigeyuki Kawa; Satoshi Kimura; S Hakomori; Yasuyuki Igarashi

In previous studies, we reported that sphingosine 1‐phosphate (Sph‐1‐P) inhibits the chemotactic motility of some cancer cell lines such as mouse melanoma cells, as well as human smooth muscle cells, at a very low concentration, as demonstrated by a transwell migration assay method (Proc. Natl. Acad. Sci. USA 89, 9698, 1992; J. Cell Biol. 130, 193, 1995). In this study, we investigated the effect of Sph‐1‐P on the chemotactic motility and invasiveness of human neutrophils, utilizing three different assay systems: (a) a transwell migration assay where IL‐8 or fLMP was added as a chemotactic factor, (b) a phagokinetic assay with gold colloids, and (c) a trans‐endothelial migration assay with human umbilical vein endothelial cells (HUVECs) plated on collagen layers. We found that among various sphingosine derivatives, Sph‐1‐P specifically inhibited the IL‐8‐ or fLMP‐induced chemotactic migration of neutrophils at concentrations below 1 μM. Phagokinetic activity of neutrophils was also suppressed by Sph‐1‐P, but more moderately than by the PKC inhibitory sphingosine analog, trimethylsphingosine. Finally, Sph‐1‐P inhibited trans‐endothelial migration and invasiveness of neutrophils into HUVEC‐covered collagen layers, whereas no effect on their adhesion to HUVECs was observed. These observations strongly suggest that Sph‐1‐P can act as a specific and effective motility regulator of human neutrophils, raising the possibility of future applications of Sph‐1‐P, or its analogs, as anti‐inflammatory agents regulating invasive migration of neutrophils through endothelial layers at injured vascular sites.


Annals of the New York Academy of Sciences | 2006

Sphingosine-1-phosphate Inhibits Haptotactic Motility by Overproduction of Focal Adhesion Sites in B16 Melanoma Cells through EDG-Induced Activation of Rho

Soichiro Yamamura; S Hakomori; Atsushi Wada; Yasuyuki Igarashi

Abstract: We investigated the molecular mechanism by which Sph‐1‐P affects the FN‐dependent haptotactic motility of serum‐starved mouse melanoma B16/F10 cells. We found that EDG‐5‐induced Rho activation followed by enhanced tyrosine phosphorylation of FAK and paxillin, and β1‐integrin activation leading to overexpression of focal adhesion sites, as well as increment of stress fiber formation, must be the molecular basis of inhibition of haptotactic cell motility by Sph‐1‐P.


Journal of Surgical Oncology | 2000

Molecular detection of disseminated cancer cells in the peripheral blood and expression of sialylated antigens in colon cancers

Daisuke Ichikawa; Kazuya Kitamura; Naoki Tani; Satoki Nishida; Hideaki Tsurutome; S Hakomori; Eito Ikeda; Fumitaka Mutoh; Hideaki Kurioka; Hisakazu Yamagishi

To improve the survival rate of patients with colon cancer, liver metastases must be eradicated in a clinically occult state. This study was designed to find a predictor for potential liver metastases or micrometastases in colon cancer.


Brazilian Journal of Medical and Biological Research | 1997

Glycosphingolipid antigens from Leishmania (L.) amazonensis amastigotes. Binding of anti- glycosphingolipid monoclonal antibodies in vitro and in vivo

Anita H. Straus; V. B. Valero; C. M. Takizawa; Steven B. Levery; Marcos S. Toledo; Erika Suzuki; Mary Ellen K. Salyan; S Hakomori; C. L. Barbieri; Helio K. Takahashi

Specific glycosphingolipid antigens of Leishmania (L.) amazonensis amastigotes reactive with the monoclonal antibodies (MoAbs) ST-3, ST-4 and ST-5 were isolated, and their structure was partially elucidated by negative ion fast atom bombardment mass spectrometry. The glycan moieties of five antigens presented linear sequences of hexoses and N-acetylhexosamines ranging from four to six sugar residues, and the ceramide moieties were found to be composed by a sphingosine d18:1 and fatty acids 24:1 or 16:0. Affinities of the three monoclonal antibodies to amastigote glycosphingolipid antigens were also analyzed by ELISA. MoAb ST-3 reacted equally well with all glycosphingolipid antigens tested, whereas ST-4 and ST-5 presented higher affinities to glycosphingolipids with longer carbohydrate chains, with five or more sugar units (slow migrating bands on HPTLC). Macrophages isolated from footpad lesions of BALB/c mice infected with Leishmania (L.) amazonensis were incubated with MoAb ST-3 and, by indirect immunofluorescence, labeling was only detected on the parasite, whereas no fluorescence was observed on the surface of the infected macrophages, indicating that these glycosphingolipid antigens are not acquired from the host cell but synthesized by the amastigote. Intravenous administration of 125I-labeled ST-3 antibody to infected BALB/c mice showed that MoAb ST-3 accumulated significantly in the footpad lesions in comparison to blood and other tissues.


Blood | 1995

Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets

Yutaka Yatomi; Fuqiang Ruan; S Hakomori; Yasuyuki Igarashi


Journal of Cell Biology | 1995

Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction.

Karin E. Bornfeldt; L M Graves; Elaine W. Raines; Yasuyuki Igarashi; G Wayman; Soichiro Yamamura; Y Yatomi; J S Sidhu; Edwin G. Krebs; S Hakomori


Journal of Biological Chemistry | 1984

Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).

Y Fukushi; E Nudelman; Steven B. Levery; S Hakomori; H Rauvala


Journal of Biological Chemistry | 1984

Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain.

S Hakomori; E Nudelman; Steven B. Levery; Reiji Kannagi


Proceedings of the National Academy of Sciences of the United States of America | 1992

Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.

Yoshito Sadahira; Fuqiang Ruan; S Hakomori; Yasuyuki Igarashi


Proceedings of the National Academy of Sciences of the United States of America | 1985

Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction

Henrik Clausen; Steven B. Levery; Edward Nudelman; S Tsuchiya; S Hakomori

Collaboration


Dive into the S Hakomori's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E Nudelman

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Mary Ellen K. Salyan

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fuqiang Ruan

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

T. Kaizu

University of Washington

View shared research outputs
Top Co-Authors

Avatar

Henrik Clausen

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Anita H. Straus

Federal University of São Paulo

View shared research outputs
Researchain Logo
Decentralizing Knowledge